IP Library Granted Patent US 9,656,096
Granted Patent B2
US 9,656,096 · App. 13/285,761 · Granted May 23, 2017

Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans

Inventor: Arthur A. Pilla (Oakland, NJ)
Assignee: Rio Grande Neurosciences, Inc.
A61N2/02A01G7/04A61N1/40A61N2/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,656,096
App. No.
13/285,761
Granted
May 23, 2017
Kind
B2
Abstract

Apparatus and methods for delivering electromagnetic signals configured specifically to accelerate the asymmetrical kinetics of the binding of intracellular ions to their respective intracellular buffers, to enhance the biochemical signaling pathways plant animal and human molecules, cells, tissues, organs, portions of entire organisms and entire organisms employ for growth, repair and maintenance. Described herein are devices and methods that utilize repetitive bursts of waveforms configured to maximize the bound concentration of intracellular ions at their associated molecular buffers to enhance the biochemical signaling pathways living systems employ for growth, repair and maintenance. For example the systems and methods described herein may drive the binding of calcium to calmodulin (CaM), thereby enhancing the CaM-dependent nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) signaling pathway.

Claims (11)

1. An electromagnetic treatment device for accelerating cytosolic ion binding to a corresponding cytosolic buffer to modulate a biochemical signaling pathway employed for tissue growth, repair and maintenance, the device configured to increase a voltage across a target ion binding pathway according to an asymmetrical binding kinetics of the target pathway, wherein the target ion binding pathway has an ion bound time, the device comprising:

a flexible and circular lightweight wire coil applicator; and

a signal generator configured to apply an electromagnetic signal to the applicator to induce, in the target pathway, a peak electric field between 1 to 100 V/m, wherein a signal generated by the signal generator has a pulse duration, random signal duration or carrier period which is less than twice the ion bound time, applied in a burst of waveforms having a pulse duration of between 1 μs and 100 μs, further wherein the signal generated has a burst duration between 1 to 10 msec of between 5 MHz to 50 MHz carrier waves, repeating between 1 and 10 bursts/sec.

2. The device of claim 1 , wherein the applicator comprises an electrode applicator.

3. The device of claim 1 , wherein the target ion binding pathway comprises calcium binding to calmodulin, and the ion bound time is between about 10 −2 -10 sec.

4. The device of claim 1 , wherein the electromagnetic treatment device is lightweight.

5. The device of claim 1 , wherein the electromagnetic treatment device is disposable.

6. The device of claim 1 , wherein the electromagnetic treatment device is portable.

7. The device of claim 1 , wherein the lightweight electromagnetic treatment device is configured to be worn.

8. The device of claim 1 , wherein the waveforms generated by the control circuit have a carrier frequency of 27.12 MHz.

9. The device of claim 1 , further comprising an anatomical support configured to hold the treatment device adjacent to a target tissue.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2024
From: ENDONOVO THERAPEUTICS, INC.
To: SOFPULSE, INC.
Reel/Frame 067933/0673 →
LICENSE Recorded Sep 24, 2019
From: RIO GRANDE NEUROSCIENCES, INC., ASSIGNOR TO ENDONOVO THERAPEUTICS INC.
To: AAH HOLDINGS LLC
Reel/Frame 050475/0809 →
SECURITY AGREEMENT Recorded Feb 1, 2018
From: ENDONOVO THERAPEUTICS, INC.
To: STEVEN M. GLUCKSTERN
Reel/Frame 045221/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2018
From: RIO GRANDE NEUROSCIENCES, INC.
To: ENDONOVO THERAPEUTICS INC.
Reel/Frame 044644/0182 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2016
From: IVIVI HEALTH SCIENCES, LLC
To: RIO GRANDE NEUROSCIENCES, INC.
Reel/Frame 037445/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: IVIVI HEALTH SCIENCES, LLC
To: RIO GRANDE NEUROSCIENCES, INC.
Reel/Frame 037394/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2012
From: PILLA, ARTHUR A.
To: IVIVI HEALTH SCIENCES, LLC
Reel/Frame 028100/0185 →
Continuity (22)
Continuation In Part 12819956 · Jun 21, 2010
Continuation In Part 12772002 · Apr 30, 2010
Continuation 11003108 · Dec 3, 2004
Continuation In Part 11114666 · Apr 26, 2005
Continuation In Part 11110000 · Apr 19, 2005
Continuation In Part 11369308 · Mar 6, 2006
Continuation In Part 11369309 · Mar 6, 2006
Continuation In Part 11223073 · Sep 10, 2005
Continuation In Part 11339204 · Jan 25, 2006
Continuation In Part 11818065 · Jun 12, 2007
Continuation In Part 11903294 · Sep 20, 2007
Continuation In Part 11977043 · Oct 22, 2007
Provisional Application 61456036 · Oct 29, 2010
Provisional Application 60527327 · Dec 5, 2003
Provisional Application 60564887 · Apr 26, 2004
Provisional Application 60563104 · Apr 19, 2004
Provisional Application 60658967 · Mar 7, 2005
Provisional Application 60658968 · Mar 7, 2005
Provisional Application 60812841 · Jun 12, 2006
Provisional Application 60846126 · Sep 20, 2006
Provisional Application 60852927 · Oct 20, 2006
Related Publication 20120089201A1 · Apr 12, 2012